Pharmagreen Biotech Total Asset vs. Shares Outstanding
| PHBI Stock | USD 0 0.0001 5.88% |
For Pharmagreen Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pharmagreen Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pharmagreen Biotech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pharmagreen Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pharmagreen Biotech over time as well as its relative position and ranking within its peers.
Pharmagreen |
Pharmagreen Biotech Shares Outstanding vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pharmagreen Biotech's current stock value. Our valuation model uses many indicators to compare Pharmagreen Biotech value to that of its competitors to determine the firm's financial worth. Pharmagreen Biotech is rated below average in total asset category among its peers. It is regarded fourth in shares outstanding category among its peers creating about 2,176 of Shares Outstanding per Total Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value Pharmagreen Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pharmagreen Biotech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Pharmagreen Shares Outstanding vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Pharmagreen Biotech |
| = | 208.97 K |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Pharmagreen Biotech |
| = | 454.76 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Pharmagreen Shares Outstanding Comparison
Pharmagreen Biotech is currently under evaluation in shares outstanding category among its peers.
Pharmagreen Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pharmagreen Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pharmagreen Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Pharmagreen Biotech's change in net profit over the period of time. It can combine multiple indicators of Pharmagreen Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada. Pharmagreen Biotech is traded on OTC Exchange in the United States.
Pharmagreen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pharmagreen Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pharmagreen Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pharmagreen Biotech's important profitability drivers and their relationship over time.
Use Pharmagreen Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pharmagreen Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmagreen Biotech will appreciate offsetting losses from the drop in the long position's value.Pharmagreen Biotech Pair Trading
Pharmagreen Biotech Pair Trading Analysis
The ability to find closely correlated positions to Pharmagreen Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharmagreen Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharmagreen Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharmagreen Biotech to buy it.
The correlation of Pharmagreen Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pharmagreen Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pharmagreen Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pharmagreen Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Pharmagreen Biotech position
In addition to having Pharmagreen Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Pharmagreen Pink Sheet
To fully project Pharmagreen Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Pharmagreen Biotech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Pharmagreen Biotech's income statement, its balance sheet, and the statement of cash flows.